Table of Contents

1. Introduction

 1.1 Biobanking Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Biobanking Market Snapshot

 2.2 Biobanking Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Biobanking Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Biobanking Market Size By Product

  2.3.2 Biobanking Market Size By Service

  2.3.3 Biobanking Market Size By Biospecimen Type

  2.3.4 Biobanking Market Size By Biobanks Type

  2.3.5 Biobanking Market Size By Application

  2.3.6 Biobanking Market Size By Biobanks Ownership

  2.3.7 Biobanking Market Size By End-use

 2.4 Biobanking Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Biobanking Market Overview

 3.1 Biobanking Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Biobanking Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Biobanking Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Biobanking Market Overview

 3.7 Biobanking Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Pricing Analysis & Forecast

  4.1.1 Overview

  4.1.2 Average Cost Per Biospecimen Storage by Sample Type (Tissue, Blood, Stem Cells)

  4.1.3 Pricing Benchmarking by Biobank Ownership Type (Academic, Private, Government)

  4.1.4 Regional Pricing Variations for Biobanking Services & Cold Chain Logistics

  4.1.5 Emerging Pricing Models (Subscription-Based Access, Pay-Per-Use Biorepository Services)

4.2 Regulatory & Compliance Landscape

  4.2.1 Overview

  4.2.2 Compliance with GDPR, HIPAA, and International Ethical Guidelines for Biobanking

  4.2.3 Informed Consent Frameworks & Patient Data Privacy Regulations

  4.2.4 Certifications and Accreditation Standards (ISO 20387, CAP, CLIA, GLP)

  4.2.5 Strategic Guidelines for Regulatory Compliance and Audit Readiness

4.3 Technology & Innovation Metrics

  4.3.1 Overview

  4.3.2 Adoption Rate of Automated Biobanking Systems & Robotics

  4.3.3 Investment in Cryopreservation Technologies & Long-Term Sample Viability Solutions

  4.3.4 Patent Filings and Technological Innovations in Biorepository & LIMS Platforms

  4.3.5 Emerging Trends: AI-Powered Sample Matching, Blockchain for Chain of Custody, IoT-Enabled Cold Chain Monitoring

4.4 Operational & Quality Metrics

  4.4.1 Overview

  4.4.2 Number of Active Biobanks Globally & Total Stored Biospecimens

  4.4.3 Biobank Utilization Rate & Sample Retrieval Success Rates

  4.4.4 Average Sample Storage Duration & Annual Sample Throughput

  4.4.5 Quality Control Metrics: Freezer Failure Rates, Temperature Excursions, & Sample Integrity

4.5 Investment & Strategic Activity

  4.5.1 Overview

  4.5.2 Venture Capital and Private Equity Investments in Biobanking Infrastructure

  4.5.3 Key M&A Activity and Strategic Partnerships in Biorepository Services

  4.5.4 Collaborations Between Pharmaceutical Companies, Academic Biobanks, and CROs

  4.5.5 Emerging Innovation Hubs and R&D Centers for Biobanking & Precision Medicine

5. Biobanking Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Biobanking Equipment

  5.2.1 Key Trends

  5.2.2 Biobanking Market Size & Forecast, 2022–2035

 5.3 Biobanking Consumables

 5.4 Laboratory Information Management Systems

6. Biobanking Market Segmental Analysis & Forecast, By Service, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Biobanking & Repository

  6.2.1 Key Trends

  6.2.2 Biobanking Market Size & Forecast, 2022–2035

 6.3 Lab Processing

 6.4 Qualification/Validation

 6.5 Cold Chain Logistics

 6.6 Other Services

7. Biobanking Market Segmental Analysis & Forecast, By Biospecimen Type, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Human Tissues

  7.2.1 Key Trends

  7.2.2 Biobanking Market Size & Forecast, 2022–2035

 7.3 Human Organs

 7.4 Stem Cells

 7.5 Other Biospecimens

8. Biobanking Market Segmental Analysis & Forecast, By Biobanks Type, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Physical/Real Biobanks

  8.2.1 Key Trends

  8.2.2 Biobanking Market Size & Forecast, 2022–2035

 8.3 Virtual Biobanks

9. Biobanking Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    9.1 Introduction

 9.2 Therapeutics

  9.2.1 Key Trends

  9.2.2 Biobanking Market Size & Forecast, 2022–2035

 9.3 Drug Discovery & Clinical Research

 9.4 Clinical Diagnostics

 9.5 Other Applications

10. Biobanking Market Segmental Analysis & Forecast, By Biobanks Ownership, 2022–2035, Value (USD Billion)

    10.1 Introduction

 10.2 University Owned

  10.2.1 Key Trends

  10.2.2 Biobanking Market Size & Forecast, 2022–2035

 10.3 National/Regional Agencies Owned

 10.4 Non-profit Organizations Owned

 10.5 Private Organization Owned

11. Biobanking Market Segmental Analysis & Forecast, By End-use, 2022–2035, Value (USD Billion)

    11.1 Introduction

 11.2 Pharmaceutical & Biotechnology Companies

  11.2.1 Key Trends

  11.2.2 Biobanking Market Size & Forecast, 2022–2035

 11.3 CROs & CMOs

 11.4 Academic & Research Institutes

 11.5 Hospitals

12. Biobanking Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

12.1 Introduction

12.2 North America

 12.2.1 Key Trends

 12.2.2 Biobanking Market Size & Forecast, By Product, 2022–2035

 12.2.3 Biobanking Market Size & Forecast, By Service, 2022–2035

 12.2.4 Biobanking Market Size & Forecast, By Biospecimen Type, 2022–2035

 12.2.5 Biobanking Market Size & Forecast, By Biobanks Type, 2022–2035

 12.2.6 Biobanking Market Size & Forecast, By Application, 2022–2035

 12.2.7 Biobanking Market Size & Forecast, By Biobanks Ownership, 2022–2035

 12.2.8 Biobanking Market Size & Forecast, By End-use, 2022–2035

 12.2.9 Biobanking Market Size & Forecast, By Country, 2022–2035

  12.2.9.1 USA

  12.2.9.2 Canada

12.3 Europe

 12.3.1 Key Trends

 12.3.2 Biobanking Market Size & Forecast, By Product, 2022–2035

 12.3.3 Biobanking Market Size & Forecast, By Service, 2022–2035

 12.3.4 Biobanking Market Size & Forecast, By Biospecimen Type, 2022–2035

 12.3.5 Biobanking Market Size & Forecast, By Biobanks Type, 2022–2035

 12.3.6 Biobanking Market Size & Forecast, By Application, 2022–2035

 12.3.7 Biobanking Market Size & Forecast, By Biobanks Ownership, 2022–2035

 12.3.8 Biobanking Market Size & Forecast, By End-use, 2022–2035

 12.3.9 Biobanking Market Size & Forecast, By Country, 2022–2035

  12.3.9.1 Germany

  12.3.9.2 UK

  12.3.9.3 France

  12.3.9.4 Italy

  12.3.9.5 Spain

  12.3.9.6 Russia

  12.3.9.7 Poland

  12.3.9.8 Rest of Europe

12.4 Asia-Pacific

 12.4.1 Key Trends

 12.4.2 Biobanking Market Size & Forecast, By Product, 2022–2035

 12.4.3 Biobanking Market Size & Forecast, By Service, 2022–2035

 12.4.4 Biobanking Market Size & Forecast, By Biospecimen Type, 2022–2035

 12.4.5 Biobanking Market Size & Forecast, By Biobanks Type, 2022–2035

 12.4.6 Biobanking Market Size & Forecast, By Application, 2022–2035

 12.4.7 Biobanking Market Size & Forecast, By Biobanks Ownership, 2022–2035

 12.4.8 Biobanking Market Size & Forecast, By End-use, 2022–2035

 12.4.9 Biobanking Market Size & Forecast, By Country, 2022–2035

  12.4.9.1 China

  12.4.9.2 India

  12.4.9.3 Japan

  12.4.9.4 South Korea

  12.4.9.5 Australia

  12.4.9.6 ASEAN Countries

  12.4.9.7 Rest of Asia-Pacific

12.5 Latin America

 12.5.1 Key Trends

 12.5.2 Biobanking Market Size & Forecast, By Product, 2022–2035

 12.5.3 Biobanking Market Size & Forecast, By Service, 2022–2035

 12.5.4 Biobanking Market Size & Forecast, By Biospecimen Type, 2022–2035

 12.5.5 Biobanking Market Size & Forecast, By Biobanks Type, 2022–2035

 12.5.6 Biobanking Market Size & Forecast, By Application, 2022–2035

 12.5.7 Biobanking Market Size & Forecast, By Biobanks Ownership, 2022–2035

 12.5.8 Biobanking Market Size & Forecast, By End-use, 2022–2035

 12.5.9 Biobanking Market Size & Forecast, By Country, 2022–2035

  12.5.9.1 Brazil

  12.5.9.2 Argentina

  12.5.9.3 Mexico

  12.5.9.4 Colombia

  12.5.9.5 Rest of Latin America

12.6 Middle East & Africa

 12.6.1 Key Trends

 12.6.2 Biobanking Market Size & Forecast, By Product, 2022–2035

 12.6.3 Biobanking Market Size & Forecast, By Service, 2022–2035

 12.6.4 Biobanking Market Size & Forecast, By Biospecimen Type, 2022–2035

 12.6.5 Biobanking Market Size & Forecast, By Biobanks Type, 2022–2035

 12.6.6 Biobanking Market Size & Forecast, By Application, 2022–2035

 12.6.7 Biobanking Market Size & Forecast, By Biobanks Ownership, 2022–2035

 12.6.8 Biobanking Market Size & Forecast, By End-use, 2022–2035

 12.6.9 Biobanking Market Size & Forecast, By Country, 2022–2035

  12.6.9.1 UAE

  12.6.9.2 Saudi Arabia

  12.6.9.3 Qatar

  12.6.9.4 Egypt

  12.6.9.5 South Africa

  12.6.9.6 Rest of Middle East & Africa

13. Competitive Landscape

 13.1 Key Players' Positioning

 13.2 Competitive Developments

  13.2.1 Key Strategies Adopted (%), By Key Players, 2025

  13.2.2 Year-Wise Strategies & Development, 2022–2025

  13.2.3 Number Of Strategies Adopted By Key Players, 2025

 13.3 Biobanking Market Share Analysis, 2025

 13.4 Product/Service & Application Benchmarking

  13.4.1 Product/Service Specifications & Features By Key Players

  13.4.2 Product/Service Heatmap By Key Players

  13.4.3 Application Heatmap By Key Players

 13.5 Industry Start-Up & Innovation Landscape

13.6 Key Company Profiles

13.6.1 Thermo Fisher Scientific Inc.

 13.6.1.1 Company Overview & Snapshot

 13.6.1.2 Product/Service Portfolio

 13.6.1.3 Key Company Financials

 13.6.1.4 SWOT Analysis

13.6.2 Merck KGaA

13.6.3 BioIVT

13.6.4 Charles River Laboratories International, Inc.

13.6.5 Hamilton Company

13.6.6 Brooks Life Sciences

13.6.7 Precision for Medicine

13.6.8 STEMCELL Technologies Inc.

13.6.9 Coriell Institute for Medical Research

13.6.10 Lonza Group Ltd.

13.6.11 Azenta Life Sciences

13.6.12 Biolife Solutions, Inc.

13.6.13 Labcorp Drug Development

13.6.14 Qiagen N.V.

13.6.15 PHC Holdings Corporation (PHCbi)

13.6.16 Worthington Industries (Taylor Wharton)

13.6.17 Cryoport, Inc.

13.6.18 So-Low Environmental Equipment Co., Inc.

13.6.19 PromoCell GmbH

13.6.20 AMSBIO

13.6.21 GenVault (acquired by IntegenX)

13.6.22 Bay Biosciences LLC

13.6.23 CTI Biotech

13.6.24 Firalis S.A.

13.6.25 BioRep S.p.A.

14. Analyst Recommendations

 14.1 SNS Insider Opportunity Map

 14.2 Industry Low-Hanging Fruit Assessment

 14.3 Biobanking Market Entry & Growth Strategy

 14.4 Analyst Viewpoint & Suggestions on Biobanking Market Growth

15. Assumptions

16. Disclaimer

17. Appendix

 17.1 List Of Tables

 17.2 List Of Figures